Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium-dependent neutral amino acid transporter B0AT1 (encoded by the SLC6A19 gene) is the major epithelial transporter responsible for the absorption of neutral amino acids in the small intestine and their reabsorption in the proximal tubules of the kidney. It operates as a sodium-coupled symporter, co-transporting one sodium ion with one neutral amino acid across the apical membrane. B0AT1 requires accessory proteins, such as collectrin (TMEM27) in the kidney and angiotensin-converting enzyme 2 (ACE2) in the intestine, for its trafficking, surface expression, and catalytic activity.
Inhibition of B0AT1 has emerged as a promising therapeutic strategy for metabolic and genetic disorders. In phenylketonuria (PKU), blocking B0AT1 reduces the absorption and reabsorption of phenylalanine, promoting its excretion in urine and lowering toxic plasma phenylalanine levels. In chronic kidney disease (CKD), B0AT1 inhibition reduces the metabolic overload of amino acids in the proximal tubules, potentially slowing disease progression. Furthermore, B0AT1 inhibition mimics dietary protein restriction, which improves glycemic control and insulin sensitivity by upregulating beneficial metabolic hormones like FGF21 and GLP-1, offering a novel approach for treating type 2 diabetes and obesity. Investigational small-molecule inhibitors, such as JNT-517, MZE782, and GenSci144, are currently in clinical development.
Allosteric inhibition of the transporter, stabilizing the outward-open conformation and preventing transition to the inward-open state, thereby blocking neutral amino acid transport.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium-dependent neutral amino acid transporter B0AT1 (B0AT1).